HIV and Disability Updating the Social Security Listings (2010) / Chapter Skim
Currently Skimming:
6 HIV-Associated Conditions With Listings Elsewhere
6 HIV-Associated Conditions With Listings Elsewhere
Pages 77-86
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 77... ...
Although HIV infection increases the risk for developing these conditions and in some instances accelerates the rate of disease progression, the comorbid conditions in Box 6-1 are generally not clinically distinct and can be evaluated adequately using the current listing criteria.
|
From page 78... ...
. The risk factors for cardiovascular disease in HIV-infected populations are the same as those in the general population, including smoking, older age, diabetes, male gender, and other prior cardiovascular conditions (Currier et al., 2008; Glass et al., 2006)
|
From page 79... ...
Although the literature about the relationship between chronic kidney disease and HIV and its treatment is still developing, the incidence of chronic kidney disease appears to be slowing. Incidence of chronic kidney disease decreased significantly after the introduction of combination antiretroviral therapy.
|
From page 80... ...
HIV-associated nephropathy is not specifically mentioned in the Genitourinary Impairment Listings, but because it has the same end result as renal failure it is adequately covered by those listings. Furthermore, SSA may wish to consider adopting changes to the aforementioned guidelines for managing chronic kidney disease in HIV patients in the future as a method of keeping up with advances in treatment.
|
From page 81... ...
. In the Swiss HIV Cohort Study, the risk for developing diabetes was associated with protease inhibitors and nucleoside reverse transcriptase inhibitor therapy (Ledergerber et al., 2007)
|
From page 82... ...
, to better reflect the current state of hepatitis care. This includes stating that HIV infection may accelerate the clinical course of viral hepatitis infection and patients infected with HIV may have a poorer response to treatment instead of simply stating that it may affect the clinical course of disease; including hepatitis B virus DNA as a method of diagnosing hepatitis B infection; revising "hepatitis B envelope antigen" to "hepatitis B early antigen" or "hepatitis B ‘e' antigen"; adding "hepatocellular carcinoma" to end-stage liver disease and cirrhosis as a condition with increased risk of progression; and removing "combination of interferon injections" as a method of suppressing hepatitis B virus.
|
From page 83... ...
Nonnucleoside reverse transcriptase inhibitors may be associated with an increased risk of Hodgkin's lymphoma (Powles et al., 2009) , and an increase in cancer was reported with an early CCR5 inhibitor, but the literature is limited about the effects of specific classes of antiretroviral therapy on developing malignancies.
|
From page 84... ...
First, the duration of these allowances should follow the durations identified by the other sublistings. However, if the literature is found to show that HIV coinfection causes changes to the disease not effectively captured in other disability listings, SSA may want to consider adding the disease to the HIV Infection Listings.
|
From page 85... ...
2005. Guidelines for the management of chronic kidney disease in HIV-infected patients: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America.
|
From page 86... ...
2010. Risk of myocardial infarction in patients with HIV infection exposed to spe cific individual antiretroviral drugs from the 3 major drug classes: The data collection on adverse events of anti-HIV drugs (D:A:D)
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.